Science
Mechanism of Action
Mitoquinol Mesylate, a specialized form of CoQ10, is engineered with a triphenylphosphonium cation, enabling its direct and efficient delivery into the mitochondrial matrix. Once within the mitochondria, it acts as a powerful antioxidant by neutralizing free radicals and significantly reducing reactive oxygen species (ROS). This action mitigates oxidative stress, protecting crucial mitochondrial and cellular structures, including DNA. This protective effect is theorized to rejuvenate skin cells by reducing cellular senescence and stimulating the production of essential structural proteins like collagen and elastin, leading to enhanced skin structure, improved hydration, and facilitated cellular repair.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 A preclinical study indicated Mitoquinol Mesylate's potential to rejuvenate skin cells by reducing cellular senescence, increasing telomere length, and improving overall skin structure, mimicking that of younger individuals in skin cells from women around 40 years of age. A specific concentration for topical application was not specified.
Transparency
Dusting Analysis
The provided data primarily highlights oral dietary supplement uses, without specific topical cosmetic formulation examples or common usage percentages that would suggest 'dusting' in cosmetics.
The Formula
Formulation
Stability
Mitoquinol Mesylate exhibits stability as a crystalline solid and in solid-state aliquots, allowing for a significantly extended shelf life compared to aqueous solutions. Its stability in aqueous solutions is limited, thus storage of such solutions beyond one day is not recommended. For stock solution preparation, it is crucial to use fresh, anhydrous DMSO as moisture-contaminated DMSO may reduce solubility.
Safety
Safety Profile
Mitoquinone mesylate has shown no genotoxic potential in both in vitro and in vivo assays when evaluated for food ingredient purposes. An oral toxicity study in dogs, at concentrations up to 40 mg/kg/day, observed only local gastrointestinal disturbances (fecal issues, vomiting) and no adverse systemic toxicity. Oral consumption of 20 mg/day has been safely utilized in human clinical trials, with a low likelihood of significant gastrointestinal complaints. However, specific FDA regulatory status for cosmetic use is not available in the provided data, and existing clinical trials are contextually related to oral supplementation for viral prophylaxis.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While preclinical evidence suggests promising cellular rejuvenation capabilities as a mitochondria-targeted antioxidant, comprehensive clinical data regarding Mitoquinol Mesylate's topical efficacy and safety for cosmetic use remains insufficient for a definitive assessment.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources